Indaptus Therapeutics is trading 5.3% up at $1.38 as the stock stages a technical rebound following a sharp multi-day selloff.
- The recovery follows a period of significant volatility and a notable drop during yesterday’s after-hours session.
- No new company-specific news or fundamental catalysts have been reported to account for the move.
- Current price action appears driven by broader risk-on market sentiment and technical buying interest rather than fresh developments.